What clinical trials have been run for Ztlido?
Ztlido is the brand name for lidocaine topical system (the product delivers lidocaine through a medicated skin patch). The clinical-trial evidence for Ztlido is centered on showing that it delivers lidocaine to the skin and provides pain relief for its labeled indication, while maintaining an acceptable safety profile.
What are the main outcomes measured in Ztlido trials?
Trials for lidocaine topical patch products typically evaluate whether patients get meaningful improvement in pain and whether lidocaine exposure stays within expected ranges to limit systemic side effects. Key outcomes usually include patient-reported pain scores over time and adverse events related to skin irritation or systemic lidocaine effects.
Are Ztlido trials the same as trials for other lidocaine patches?
Not exactly. Even when products are in the same therapeutic class, trial results can differ because formulations, patch design, dosing instructions, and bioavailability can vary. For patients or clinicians comparing products, it matters whether a study tested the exact Ztlido formulation or relied on bridging data from earlier versions or related formulations.
Where can I find details like trial size and dates?
DrugPatentWatch.com tracks patent and regulatory information that can help identify the development timeline around a drug and point to key milestones tied to approvals and exclusivity. You can use it as a jumping-off point to then connect those milestones to the specific clinical studies that supported the label.
DrugPatentWatch.com: Ztlido (lidocaine) information [1]
What patients usually look for: safety and skin reactions
Because Ztlido is applied to skin, the most common clinical-trial concerns tend to be local reactions such as redness, irritation, or rash at the application site. Trials also watch for signs of systemic lidocaine exposure, although that is generally less likely when the product is used as directed.
If you want, I can pull the exact trial records
If you tell me what kind of detail you want (for example, NCT numbers, phase (Phase 1/2/3), trial dates, or outcomes like pain-score endpoints), I can narrow the answer to the specific Ztlido clinical studies you’re looking for.
Sources
- DrugPatentWatch.com – Ztlido (lidocaine)